Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic Nephropathy”

285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 285 results

Not applicableTemporarily pausedNCT03921216
What this trial is testing

Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.

Who this might be right for
Diabetes Mellitus, Type 2Diabetic NephropathiesChronic Kidney Diseases
Karolinska University Hospital 20
Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Testing effectiveness (Phase 2)Study completedNCT00097955
What this trial is testing

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Who this might be right for
Diabetic Nephropathy
Novartis Pharmaceuticals 496
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Not applicableNot Yet RecruitingNCT07173686
What this trial is testing

Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Assiut University 80
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Post-approval studies (Phase 4)Looking for participantsNCT05390892
What this trial is testing

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Who this might be right for
Type2DiabetesASCVD
Brigham and Women's Hospital 6,000
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Testing effectiveness (Phase 2)Study completedNCT01667614
What this trial is testing

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusDiabetic NephropathyEssential Hypertension
Tehran University of Medical Sciences 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07325201
What this trial is testing

Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring

Who this might be right for
Type 1 Diabetes MellitusChronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease
HealthPartners Institute 80
Not applicableUnknownNCT02409511
What this trial is testing

Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

Who this might be right for
MicroalbuminuriaEndothelial DysfunctionDiabetic Nephropathy+1 more
Hospital Universitari Vall d'Hebron Research Institute 75
Post-approval studies (Phase 4)Study completedNCT00234871
What this trial is testing

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Who this might be right for
HypertensionDiabetesProteinuria
Abbott 357
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Large-scale testing (Phase 3)UnknownNCT04531163
What this trial is testing

Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy

Who this might be right for
Diabetic Kidney DiseaseDiabetes Mellitus, Type 2Diabetic Nephropathies
Al-Azhar University 60
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Not applicableStudy completedNCT02704884
What this trial is testing

Microbial Soy Milk Consumption, Inflammation and Renal Function Among Type 2 Diabetic Patients With Nephropathy

Who this might be right for
Type II Diabetic Patients With Nephropathy
Isfahan University of Medical Sciences 48
Large-scale testing (Phase 3)Study completedNCT00556465
What this trial is testing

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyChronic Kidney DiseaseDiabetes Type 2
Shiraz University of Medical Sciences 60
Not applicableNot Yet RecruitingNCT07169422
What this trial is testing

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Nova Scotia Health Authority 120
Testing effectiveness (Phase 2)Study completedNCT00287183
What this trial is testing

6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Who this might be right for
Diabetic Nephropathy
Pfizer 110
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Load More Results